Diabetic foot ulcers therapeutics market expected to maintain a moderate growth

NewsBot · Jul 13, 2012

Members do not see these Ads. Sign Up.
Press Release:
Diabetic foot ulcers therapeutics market expected to maintain a moderate growth

The diabetic foot ulcers therapeutics market is expected to maintain a moderate growth over the coming years, having increased from a market value of £1.13 billion in 2006, to reach $1.53 billion by 2011. By 2019 it is predicted that the diabetic foot ulcers market will continue this growth and will hit a market value of $1.97 billion.

Diabetic foot ulcers can drastically impair quality of life and are a cause of significant morbidity, accounting for 20% of all diabetes-related hospital admissions in the US.

The diabetic foot ulcers market is made up of the diabetic foot infection (DFI) and wound healing sectors, with the two experiencing differing fortunes within the market.

On one hand the diabetic foot infection market experienced a positive growth, climbing from $1 billion to reach $1.6 billion, but the wound healing sector experienced a very different fate.

The wound healing market dropped from $126.5m in 2006, to $73.8m in 2011, dropping at a negative compound annual growth rate (CAGR) of 10.2%. This market decline can be attributed to the fact that the US Food and Drugs Administration (FDA) slapped a 'black box' warning on their only product, Regranex, due to concerns that large quantities could increase the risk of cancer by up to five times.

None the less, the DFI sector was also not without its woes. The three major drugs in this area all have side effect issues. Given the problems with these current treatments, it appears there are opportunities for new drugs to push through and make an impression on the diabetic foot ulcers therapeutics market.
Click to expand...

Full report

NewsBot · Jan 10, 2013

Press Release:
Research and Markets: Diabetic Foot Ulcers - Pipeline Review, H2 2012

Research and Markets (http://www.researchandmarkets.com/research/dfnjcm/diabetic_foot) has announced the addition of Global Markets Direct's new report "Diabetic Foot Ulcers - Pipeline Review, H2 2012" to their offering.

Global Markets Direct's, 'Diabetic Foot Ulcers - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Diabetic Foot Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetic Foot Ulcers.

Scope

- A snapshot of the global therapeutic scenario for Diabetic Foot Ulcers.

- A review of the Diabetic Foot Ulcers products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Diabetic Foot Ulcers pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- News and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Diabetic Foot Ulcers.

- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.

- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.

- Devise corrective measures for pipeline projects by understanding Diabetic Foot Ulcers pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

For more information visit http://www.researchandmarkets.com/research/dfnjcm/diabetic_foot
Click to expand...

NewsBot The Admin that posts the news.

NewsBot The Admin that posts the news.

Homeopathy for Diabetic Foot Ulcers

The role of programmed cell death in diabetic foot ulcers

Topical Medications for Treating Diabetic Foot Ulcers - A Systematic Review

Boron based gel for the treatment of diabetic foot ulcers

Topical Esmolol Hydrochloride for Diabetic Foot Ulcers

Diabetic Foot Ulcers in Skin of Color

Leech therapy and Ayurveda for diabetic foot ulcers

Share This Page